Tuberculosis

For further information about tuberculosis contact:
Information Resource Centre HTM/STB
World Health Organization
20 Avenue Appia, 1211–Geneva–27, Switzerland
Email: tbdocs@who.int
Web site: www.who.int/tb
ISBN 978 92 4 156406 9

Global Tuberculosis Control WHO REPORT 2010

The World Health Organization monitors
the global tuberculosis epidemic in support
of national TB controlprogrammes.

Global
Tuberculosis
Control
2010

ACSM
AFR
AIDS
AMR
ARI
ART
CDR
CPT
CBC
DOT
DOTS
DRS
DST
ECDC
EMR
EU
EUR
FIND
GDF
GLC
GLI
Global Fund
Global Plan
GNI
HBC
HIV
HRD
ICD-10
IPT
IRR
ISTC
LED
LPA
MDG
MDR-TB
NGO
NTP
PAL
PPM
SEAR
TB
UNAIDS
UNITAID
USAID
VR
WHA
WHO
WPR
XDR-TB
ZN

advocacy, communication and social mobilization
WHOAfrican Region
acquired immunodeficiency syndrome
WHO Region of the Americas
annual risk of infection
antiretroviral therapy
case detection rate
co-trimoxazole preventive therapy
community-based TB care
directly observed treatment
the basic package that underpins the Stop TB Strategy
drug resistance surveillance or survey
drug susceptibility testing
European Centre for Disease Prevention andControl
WHO Eastern Mediterranean Region
European Union
WHO European Region
Foundation for Innovative New Diagnostics
Global TB Drug Facility
Green Light Committee
Global Laboratory Initiative
The Global Fund to fight AIDS, Tuberculosis and Malaria
Global Plan to Stop TB, 2011–2015
gross national income
high-burden country of which there are 22 that account for approximately 80% of allnew TB cases
arising each year
human immunodeficiency virus
Human resource development
International Classification of Diseases (tenth revision)
isoniazid preventive therapy
incidence rate ratio
International Standards for Tuberculosis Care
Light-emitting diode
Line-probe assay
Millennium Development Goal
multidrug-resistant tuberculosis (resistance to, at least, isoniazid andrifampicin)
nongovernmental organization
national tuberculosis control programme or equivalent
Practical Approach to Lung Health
Public–Private Mix
WHO South-East Asia Region
tuberculosis
Joint United Nations Programme on HIV/AIDS
international facility for the purchase of diagnostics and drugs for diagnosis and treatment of HIV/
AIDS, malaria and TB
United States Agency for InternationalDevelopment
Vital registration
World Health Assembly
World Health Organization
WHO Western Pacific Region
Extensively drug-resistant TB
Ziehl-Neelsen

his report on global tuberculosis control was produced by a core team of 12 people: Léopold Blanc, Dennis Falzon,
Christopher Fitzpatrick, Katherine Floyd, Inés Garcia, Christopher Gilpin, Philippe Glaziou, Tom Hiatt, Delphine
Sculier,Charalambos Sismanidis, Hazim Timimi and Mukund Uplekar. The team was led by Katherine Floyd and
Léopold Blanc. Overall guidance was provided by the Director of the Stop TB Department, Mario Raviglione.
The data collection forms (long and short versions) were developed by Philippe Glaziou, with input from staff
throughout the Stop TB Department. Hazim Timimi led and organized all aspects of datamanagement, with support from Tom Hiatt. Christopher Fitzpatrick and Inés Garcia conducted all review and follow-up of financial data.
Annemieke Brands, Dennis Falzon, Christopher Gilpin, Malgosia Grzemska, Christian Gunneberg, Tom Hiatt, Eva
Nathanson, Salah Ottmani, Delphine Sculier, Hazim Timimi, Wayne Van Gemert, Fraser Wares, Matteo Zignol and
four colleagues from the Global Fund – Nino Mdivani,Sai Pothapregada, John Puvimanasinghe and Lal Sadasivan
Sreemathy – conducted the review and follow-up of data related to epidemiology and the implementation of the
Stop TB Strategy. Data for the European Region were collected and validated jointly by the WHO Regional Office for
Europe and the European Centre for Disease Prevention and Control (ECDC), an agency of the European Union based...